Abstract
The authors describe course and outcome of eight patients with ischemic stroke as the first thrombotic manifestation of antiphospholipid syndrome who received low-dose aspirin as prophylactic treatment. During 8.9 years of follow-up, two patients had a recurrent stroke. Recurrent stroke rate per 100 patient-years on aspirin was 3.5 (95% CI 0.4 to 12.5).
MeSH terms
-
Adult
-
Anticoagulants / therapeutic use
-
Antiphospholipid Syndrome / complications
-
Antiphospholipid Syndrome / drug therapy*
-
Aspirin / therapeutic use*
-
Brain Ischemia / drug therapy
-
Brain Ischemia / etiology
-
Brain Ischemia / prevention & control*
-
Female
-
Follow-Up Studies
-
Humans
-
Middle Aged
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Secondary Prevention
-
Stroke / drug therapy
-
Stroke / etiology
-
Stroke / prevention & control*
-
Treatment Outcome
Substances
-
Anticoagulants
-
Platelet Aggregation Inhibitors
-
Aspirin